Martin Whyte

41PUBLICATIONS

57CO-AUTHORS

Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Foetal development and medicineImmunogenetics (incl. genetic immunology)Pharmacogenomics

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (41)

Sort by Publication Date:

|Jun 16, 2026

Combining Sodium-Glucose Co-Transporter-2 Inhibitor Plus Glucagon-Like Peptide-1 Receptor Agonist for Glucose-Lowering in Type 2 Diabetes: Effects of Drug Initiation Sequence on Kidney Function in Real-World Clinical Practice (CombiKid Study).

|May 21, 2026

A systematic review and meta-analysis of the relative benefit of dual versus single oral hypoglycaemic therapy following diagnosis with type 2 diabetes (T2D).

|Apr 22, 2026

The Risk of GLP-1 Receptor Agonist (GLP-1 RA) Exposure in Early Pregnancy. A Call to Action: Quantifying the Impact on Pregnancy Outcomes in the United Kingdom.

|Apr 17, 2026

The insulin-like growth factor system and the progression of renal complications of type 2 diabetes.

|Feb 16, 2026

Evaluating the Effects of Glucagon-Like Peptide 1 Receptor Agonists as a Secondary Prevention in Peripheral Arterial Disease: A Meta-Analysis.

Beth Elliott, Ellie Tomlinson, Nirali Desai

|Dec 31, 2025

Progression of albumin/creatinine ratio (ACR) and estimated glomerular filtration rate (eGFR) over 24 years in people with type 2 diabetes. Drivers, potential protectors and associated mortality.

Andreas Matheou, Orestis Zavlis, Steve White

Pageof 7

Frequent Collaborators

12 joint publications

Adrian Heald

Mike Stedman

Simon de Lusignan

William Hinton

Reuben M Reed

Rustam Rea

Christian Heiss

Simon S Skene

Anthony A Fryer

Michael Feher

Frequent Collaborators

12 joint publications

Adrian Heald

6 joint publications

Mike Stedman

5 joint publications

Simon de Lusignan

3 joint publications

William Hinton